Stock Market 28 May 2026 - 29 May 2026

XMax Stock Stays Close to Highs as 200 Million Shares Face Investors
·····

XMax Stock Stays Close to Highs as 200 Million Shares Face Investors

XMax closed at $8.56, up 0.12%, staying near its 52-week high as it asked shareholders to approve discounted share sales tied to its AI expansion. The company’s proxy seeks authorization to issue up to 200 million new shares, potentially at prices up to 50% below market. XMax aims to fund AI software, hardware, and cloud infrastructure. Furniture peers saw little movement.
June 1, 2026
Amdocs Stock Ticks Up While Nasdaq Hits New Highs; This Is the Filing Traders Are Watching
····

Amdocs Stock Ticks Up While Nasdaq Hits New Highs; This Is the Filing Traders Are Watching

Amdocs closed at $61.65, up 0.6%, after reporting second-quarter revenue of $1.172 billion, a 3.9% increase from last year. Net income fell to $138.8 million from $164.0 million, with diluted EPS down to $1.28 from $1.45. The company repurchased $138 million in shares and gave third-quarter revenue guidance of $1.155 billion to $1.195 billion. Trading volume reached about 908,000 shares.
May 29, 2026
eBay Bounces Back; Focus Turns to GameStop Moves
·····

eBay Bounces Back; Focus Turns to GameStop Moves

eBay shares rose 1.6% to $112.13 Thursday after rejecting GameStop CEO Ryan Cohen’s $56 billion takeover bid. GameStop’s $125-a-share offer remains far above eBay’s trading price, reflecting investor doubts. eBay’s board called the bid “neither credible nor attractive” and cited financing concerns. GameStop disclosed direct ownership of 25,000 eBay shares and economic exposure to 29.1 million more through derivatives.
May 28, 2026
BeOne Dips on Wall Street After Cancer Results, Market Looks On
·······

BeOne Dips on Wall Street After Cancer Results, Market Looks On

BeOne Medicines shares fell 2.7% to $291.98 Thursday afternoon despite positive late-stage cancer trial data, while the Nasdaq Biotechnology Index rose 1.1%. The Phase 3 HERIZON-GEA-01 trial showed BeOne’s ZIIHERA combo reached median overall survival of 26.4 months versus 19.2 months for the control. Investors appeared cautious ahead of more data expected at the ASCO meeting next week.
May 28, 2026
MapLight Stock Slips Ahead of August Drug Update
···

MapLight Stock Slips Ahead of August Drug Update

MapLight Therapeutics shares fell 1.3% to $29.17 Thursday as investors awaited Phase 2 trial results for schizophrenia and autism, expected by mid-August. The company finished enrolling 307 patients in its ZEPHYR schizophrenia study and ended March with $395.2 million in cash. Analyst price targets ranged from $28 to $48. MapLight’s lead drug targets muscarinic receptors, a newer approach in antipsychotic treatment.
May 28, 2026
Peraso Stock Pops 13% as PRSO Traders Bet a Delayed Order Is Finally Behind It
····

Peraso Stock Pops 13% as PRSO Traders Bet a Delayed Order Is Finally Behind It

Peraso Inc. shares rose about 13% Thursday, trading near $1.165 on volume of 1.29 million after closing at $1.03. The move followed weak first-quarter results, with net revenue down to $963,000 from $3.87 million a year earlier and a net loss widening to $2.5 million. Management said a delayed customer order has now shipped. No new company disclosures were issued Thursday.
May 28, 2026
Zentek Just Raised C$18 Million. The Stock Still Trades Below the Deal Price
····

Zentek Just Raised C$18 Million. The Stock Still Trades Below the Deal Price

Zentek Ltd. closed an C$18 million private placement at C$1.00 per unit, but shares traded around C$0.80 on the TSX Venture Exchange Thursday. The company plans to use proceeds for its Albany Graphite project and ZenGUARD air-filter business. Nasdaq shares remained below the $1.00 minimum bid, risking compliance. Recent government program inclusion has not yet resulted in confirmed ZenGUARD orders.
May 28, 2026
New Fortress Energy Shares Dip Under 60 Cents Ahead of Key Reverse-Split Vote
····

New Fortress Energy Shares Dip Under 60 Cents Ahead of Key Reverse-Split Vote

New Fortress Energy Inc. fell to 55.79 cents early Thursday, down 3.8%, with a market value near $159 million after releasing its annual meeting proxy. The company faces possible Nasdaq delisting after months below $1 per share and reported a Q1 net loss of $399.95 million on $226.95 million revenue. Debt stood at $8.29 billion as of March 31, with most classified as current due to defaults. Shareholders will vote June 17 on a 1-for-50 reverse split and restructuring plan.
May 28, 2026
Werner Enterprises Stock Trades Close to 52-Week High on Freight Rebound Hopes
····

Werner Enterprises Stock Trades Close to 52-Week High on Freight Rebound Hopes

Werner Enterprises traded at $40.92 before Thursday’s open, near its 52-week high, giving the company a market cap of about $2.45 billion. First-quarter revenue rose 14% to $808.6 million, with operating income at $4.0 million after a loss last year. The FirstFleet acquisition added $107.9 million in revenue but increased leverage risks. Werner’s next public appearance is set for June 9 at a Wells Fargo conference.
May 28, 2026
NewAmsterdam Pharma Stock Rises as Fresh Filing Puts Its $4.3 Billion Drug Bet in Focus
····

NewAmsterdam Pharma Stock Rises as Fresh Filing Puts Its $4.3 Billion Drug Bet in Focus

NewAmsterdam Pharma shares rose 1.3% to $36.56 Wednesday after Chief Accounting Officer Louise Frederika Kooij exercised and sold 65,000 shares, according to a Form 4 filing. A separate Form 144 listed a proposed sale of 210,000 shares for Kooij. The company awaits key regulatory decisions on its cholesterol drug obicetrapib later this year. NewAmsterdam reported a first-quarter net loss of $48.4 million.
May 28, 2026
Capitol Federal Stock Nears a 52-Week High as Traders Watch Margins, Buybacks
····

Capitol Federal Stock Nears a 52-Week High as Traders Watch Margins, Buybacks

Capitol Federal Financial shares rose to $7.80 in premarket trading Thursday after closing at $7.77, near a 52-week high. The Topeka-based bank reported fiscal Q2 net income of $20.1 million and a net interest margin of 2.24%. Commercial loans increased $39.1 million to $2.32 billion. The company repurchased 3.08 million shares and declared an 8.5-cent dividend.
May 28, 2026
DNA X Stock Looks at Nasdaq Deadline After Latest Financing
····

DNA X Stock Looks at Nasdaq Deadline After Latest Financing

DNA X said Nasdaq will delist its shares after the company fell short of stockholders’ equity rules, posting a $983,000 deficit for the March quarter. The company plans to request a hearing by May 29 to halt suspension as it appeals. DNA X shares last traded at $4.07 in premarket, valuing the firm at about $5.1 million. The company also announced a $3.05 million convertible note financing.
May 28, 2026
Carter Bankshares rally cools for now as market looks for next move
····

Carter Bankshares rally cools for now as market looks for next move

Carter Bankshares closed down 1.9% at $26.84 Wednesday, reversing part of a recent rally that brought shares near a 52-week high. Trading volume fell to 217,125 shares from 254,683 the day before. Executive vice president Jane Ann Davis sold 261 shares at $26.95 on May 21, leaving her with 13,723 shares. Carter reported first-quarter net income of $85.8 million after selling a large nonperforming loan.
May 28, 2026
1 … 3 4 5 6 7 … 126

Stock Market Today

  • Tasmea's Strategic Shift Aims to Revolutionize Electrical Services Sector
    June 1, 2026, 8:27 PM EDT. Tasmea is pursuing a significant transformation in its electrical services business, signaling a bold strategic move. While specific financial details remain undisclosed, this shift highlights the company's intent to enhance service delivery and market presence. The move could impact Tasmea's position within the electrical services market and attract investor attention. Market participants are advised to follow up with professional financial advice before making decisions, as Tasmea's plans evolve in a competitive sector.